Latest Breaking News On - Leah monteiro - Page 1 : comparemela.com

Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003

Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesGabriel brooksBo cumboLeah monteiroDrug administrationExchange commissionSolid biosciences incRare pediatric diseaseOrphan drugFast track designationsRare pediatric disease designationChief executive officerChief medical officerPediatric disease designationPrivate securities litigation reform actBiosciences contact

Solid Biosciences to Participate at Cantor s Virtual Muscular Dystrophy Symposium

Solid Biosciences to Participate at Cantor s Virtual Muscular Dystrophy Symposium
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Gabriel brooksBo cumboLeah monteiroSolid biosciences incChief executive officerChief medical officerVirtual muscular dystrophy symposiumBiosciences contactInvestor relations

Solid Biosciences Provides Fourth Quarter and Full-Year

Solid Biosciences Provides Fourth Quarter and Full-Year
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Leah monteiroGabriel brooksKevin tanBo cumboCompany updatesExchange commissionSolid biosciences incFast track designationOrphan drug designationFast trackCollaboration agreementPrivate securities litigation reform actBiosciences contactInvestor relations

Solid Biosciences Announces $109 Million Private Placement

CHARLESTOWN, Mass., Jan. 08, 2024 Solid Biosciences Inc. , a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that it has.

United statesLeah monteiroExchange commissionSolid biosciences incDeerfield management companyBain capital life sciencesGlobenewswire incManagement companyHenderson investorsPoint capitalSecurities actPrivate securities litigation reform actBiosciences contactInvestor relations

Solid Biosciences Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Gene Therapy SGT-003

– Next-generation gene transfer therapy to treat Duchenne receives FDA Fast Track Designation – CHARLESTOWN, Mass., Dec. 07, 2023 Solid Biosciences Inc. , a life sciences company.

United statesLeah monteiroBo cumboExchange commissionSolid biosciences incDrug administrationGlobenewswire incTrack designationFast track designationFast trackPrivate securities litigation reform actBiosciences contactInvestor relations